|
|
|
|
|
|
2012 Press Releases
2011 Press Releases
| November 12, 2011 |
Wockhardt's Financial Results - Q2 (Jul-Sept) FY 2011-12 Wockhardt Sales up 18% and Operating Profit up 47% Net Profit was Rs 128 crore
|
| August 9, 2011 |
Wockhardt's Financial Results - Q1 (April-June) FY 2011-12 Wockhardt's Operating Profit (EBIDTA) Rs 310.8 crore, a growth of 72.5%
Net Profit Rs 193.9 crore Consolidated Sales grew by 14.3% to Rs 1,053.2 crore
|
| July 8, 2011 |
Wockhardt receives tentative US FDA approval for generic version of depression drug Cymbalta® |
| July 1, 2011 |
Wockhardt receives tentative US FDA approval for generic version of Patanol® ophthalmic solution |
| June 21, 2011 |
Wockhardt launches three new products in three weeks, in the United States |
| May 19, 2011 |
Wockhardt's robust business backed with profits Consolidated Sales grew by 3.1% to Rs 3,751 crore Operating Profit (EBIDTA) grew by 41.7% to Rs 908.7 crore Net Profit was Rs 90.5 crore |
| April 25, 2011 |
Wockhardt receives US FDA approval for generic version of Aricept® tablets |
| April 19, 2011 |
Wockhardt receives US FDA approval for generic version of Effexor XR® capsules |
| February 02, 2011 |
Wockhardt's Q3 (October - December) FY 2011 Results Wockhardt bounces back with Profits Consolidated Sales Rs. 950.80 crore Net Profit Rs 141.7 crore Operating Profit grows at 82.0% (EBIDTA Rs 243.7 crore) |
2010 Press Releases
| November 12, 2010 |
Wockhardt's Q2 (July - September) FY 2011
Consolidated Sales Rs 940.1 crore Operating Profit (EBIDTA) Rs 219.8 crore Wockhardt's India, UK & US businesses post double-digit growth |
| October 20, 2010 |
Wockhardt receives US FDA approval for the generic version of Allegra-D® 12 hour |
| August 13, 2010 |
Wockhardt's Q1 (Apr-Jun) FY 2011 Consolidated Sales was Rs 922 crore Operating Profit (EBIDTA) was Rs 180 crore Wockhardt's US, UK & India Branded Business posts double-digit growth |
| July 23, 2010 |
Wockhardt receives US FDA approval for the generic version of Toprol XL® , a cardiac drug |
| May 20, 2010 |
Wockhardt's 15 months Sales stood at Rs 4,501 crores and Operating Profit at Rs 823 crores |
| May 15, 2010 |
Purdue University confers Habil Khorakiwala an honorary doctorate in Pharmacy |
| April 28, 2010 |
Wockhardt launches Prostate drug Tamsulosin capsules in the United States |
| January 25, 2010 |
Wockhardt's Q4 Results 2009 |
| January 13, 2010 |
Wockhardt receives US FDA approval for antibacterial Levofloxacin |
| January 06, 2010 |
Wockhardt receives US FDA approval for Alzheimer's drug Memantine |
2009 Press Releases
| November 18, 2009 |
Wockhardt launches anti-hypertensive drug Nicardipine injections in USA |
| October 31, 2009 |
Wockhardt's Q3 Results 2009 |
| October 01, 2009 |
Wockhardt receives US FDA approval for Prostate drug Alfuzosin tablets |
| September 29, 2009 |
Wockhardt receives US FDA approval for Prostate drug Tamsulosin capsules |
| July 30, 2009 |
Wockhardt’s Q2 Results 2009 |
| April 24, 2009 |
Wockhardt’s 2008 Annual Results |
| February 26, 2009 |
Wockhardt to launch generic version of
ulcer drug Ranitidine syrup in the US market |
| February 12, 2009 |
Wockhardt to launch Leveiracetam, a generic
version of epilepsy drug in the US market |
| February 11, 2009 |
Wockhardt to launch Divalproex ER in the US market |
2008 Press Releases
2007 Press Releases
|
|
